# Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

> **NCT07643233** · PHASE1 · NOT_YET_RECRUITING · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Moderate-to-severe Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** Test Drug
- **DRUG:** Reference Drug

## Key facts

- **NCT ID:** NCT07643233
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643233, "Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07643233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*